While Bagnara et al showed that depletion of T-cells in the xenografted NSG mice inhibits CLL cell proliferation,39 the effect of the emerging BCR directed therapies have not been investigated in this model. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.